Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i.v. and 300 mg p.o. in ACS (ACUTE) - Zeymer, U; Hohlfeld, T; Vom Dahl, J (Thromb Haemost, 2017)
et al.